All Stories

  1. Rodent Models of D-Galactose Induction of Accelerated Aging: A Platform for Exploring Kidney Aging Mechanisms and Anti-Kidney Aging Strategies
  2. Renoprotection by 5-Methoxytryptophan in Kidney Disease
  3. Rodent Models of D-Galactose Induction of Accelerated Aging: A Platform for Exploring Kidney Aging Mechanisms and Anti-Kidney Aging Strategies
  4. Renoprotection by 5-Methoxytryptophan in Kidney Disease
  5. The Role of Sirt3 in Kidney Health and Disease
  6. Beneficial Effects of Butyrate on Kidney Disease
  7. Mitigating Oxidative Stress and Inflammation: The Protective Role of β-lapachone in Kidney Disease
  8. Diabetic Kidney Disease: Contribution of Phenyl Sulfate Derived from Dietary Tyrosine upon Gut Microbiota Catabolism
  9. Rodent Models of Streptozotocin-Induced Diabetes as Suitable Paradigms for Studying Diabetic Kidney Disease
  10. Redox Imbalance and Mitochondrial Abnormalities in Kidney Disease—Volume II
  11. Orientin Protects BV-2 Microglial Cells against Hypoxia Reoxygenation Injury through Inhibiting Oxidative Stress
  12. Editorial: Diabetes and obesity effects on lung function, volume II
  13. Roles of Dihydrolipoamide Dehydrogenase in Health and Disease
  14. Renal-Protective Roles of Lipoic Acid in Kidney Disease
  15. Long-term intermittent fasting improves neurological function by promoting angiogenesis after cerebral ischemia via growth differentiation factor 11 signaling activation
  16. The Role of Ketone Bodies in Various Animal Models of Kidney Disease
  17. The Nicotinamide/Streptozotocin Rodent Model of Type 2 Diabetes: Renal Pathophysiology and Redox Imbalance Features
  18. Cisplatin-Induced Kidney Toxicity: Potential Roles of Major NAD+-Dependent Enzymes and Plant-Derived Natural Products
  19. Redox Imbalance and Mitochondrial Abnormalities in Kidney Disease
  20. Folic acid‐induced animal model of kidney disease
  21. Activation of peripheral group III metabotropic glutamate receptors suppressed formalin‐induced nociception
  22. Cadmium-Induced Kidney Injury: Oxidative Damage as a Unifying Mechanism
  23. Comment on Kobroob et al. Effectiveness of N-Acetylcysteine in the Treatment of Renal Deterioration Caused by Long-Term Exposure to Bisphenol A. Biomolecules 2021, 11, 655
  24. NADH/NAD+ Redox Imbalance and Diabetic Kidney Disease
  25. <p>Antioxidative and Hypoglycemic Effect of Ta-ermi Extracts on Streptozotocin-Induced Diabetes</p>
  26. Reductive Stress-Induced Mitochondrial Dysfunction and Cardiomyopathy
  27. Urine Sample-Derived Cerebral Organoids Suitable for Studying Neurodevelopment and Pharmacological Responses
  28. Regulation of the SIRT1 signaling pathway in NMDA-induced Excitotoxicity
  29. Neuroprotection of Cyperus esculentus L. orientin against cerebral ischemia/reperfusion induced brain injury
  30. Effects of mesencephalic astrocyte-derived neurotrophic factor on cerebral angiogenesis in a rat model of cerebral ischemia
  31. Effects of dietary 5-methoxyindole-2-carboxylic acid on brain functional recovery after ischemic stroke
  32. Vagus nerve stimulation as a promising adjunctive treatment for ischemic stroke
  33. Role of Catalase in Oxidative Stress- and Age-Associated Degenerative Diseases
  34. Circulating factors in young blood as potential therapeutic agents for age-related neurodegenerative and neurovascular diseases
  35. Role of pseudohypoxia in the pathogenesis of type 2 diabetes
  36. The negative and detrimental effects of high fructose on the liver, with special reference to metabolic disorders
  37. Chronic Inhibition of Mitochondrial Dihydrolipoamide Dehydrogenase (DLDH) as an Approach to Managing Diabetic Oxidative Stress
  38. Humanin Attenuates NMDA-Induced Excitotoxicity by Inhibiting ROS-dependent JNK/p38 MAPK Pathway
  39. Reexploring 5-methoxyindole-2-carboxylic acid (MICA) as a potential antidiabetic agent
  40. Mitochondrial protein sulfenation during aging in the rat brain
  41. Redox imbalance stress in diabetes mellitus: Role of the polyol pathway
  42. Post-ischemic administration of 5-methoxyindole-2-carboxylic acid at the onset of reperfusion affords neuroprotection against stroke injury by preserving mitochondrial function and attenuating oxidative stress
  43. Role and Possible Mechanisms of Sirt1 in Depression
  44. Administration of 5-methoxyindole-2-carboxylic acid that potentially targets mitochondrial dihydrolipoamide dehydrogenase confers cerebral preconditioning against ischemic stroke injury
  45. Ceruloplasmin, a Potential Therapeutic Agent for Alzheimer's Disease
  46. Pancreatic mitochondrial complex I exhibits aberrant hyperactivity in diabetes
  47. Redox imbalance and mitochondrial abnormalities in the diabetic lung
  48. Non‐Gradient Blue Native Polyacrylamide Gel Electrophoresis
  49. The Neuroprotective Effects of SIRT1 on NMDA-Induced Excitotoxicity
  50. Potential Biochemical Mechanisms of Lung Injury in Diabetes
  51. Glutaredoxins concomitant with optimal ROS activate AMPK through S-glutathionylation to improve glucose metabolism in type 2 diabetes
  52. Sources and implications of NADH/NAD+ redox imbalance in diabetes and its complications
  53. Two-dimensional gel electrophoretic detection of protein carbonyls derivatized with biotin-hydrazide
  54. Comparison of antioxidant and antiproliferative activity between Kunlun Chrysanthemum flowers polysaccharides (KCCP) and fraction PII separated by column chromatography
  55. Chemical Conditioning as an Approach to Ischemic Stroke Tolerance: Mitochondria as the Target
  56. Protein Modifications as Manifestations of Hyperglycemic Glucotoxicity in Diabetes and Its Complications
  57. Hyperglycemic Stress and Carbon Stress in Diabetic Glucotoxicity
  58. Cerebral small vessel disease and Alzheimer’s disease
  59. Role of RAGE in Alzheimer’s Disease
  60. Streptozotocin-induced type 1 diabetes in rodents as a model for studying mitochondrial mechanisms of diabetic β cell glucotoxicity
  61. Activation of mTOR: a culprit of Alzheimer’s disease?
  62. Two dimensional blue native/SDS-PAGE to identify mitochondrial complex I subunits modified by 4-hydroxynonenal (HNE)
  63. Antioxidant Activity, Antitumor Effect, and Antiaging Property of Proanthocyanidins Extracted fromKunlun ChrysanthemumFlowers
  64. Roles of Pyruvate, NADH, and Mitochondrial Complex I in Redox Balance and Imbalance inβCell Function and Dysfunction
  65. Mitochondrial Dihydrolipoamide Dehydrogenase Is Upregulated in Response to Intermittent Hypoxic Preconditioning
  66. Role of insulin resistance in Alzheimer’s disease
  67. PTEN degradation after ischemic stroke: A double-edged sword
  68. Cancer-associated Isocitrate Dehydrogenase 1 (IDH1) R132H Mutation and D-2-Hydroxyglutarate Stimulate Glutamine Metabolism under Hypoxia
  69. Protein Redox Modification as a Cellular Defense Mechanism against Tissue Ischemic Injury
  70. Positive oxidative stress in aging and aging-related disease tolerance
  71. Pathogenesis of Chronic Hyperglycemia: From Reductive Stress to Oxidative Stress
  72. Microglia, neuroinflammation, and beta-amyloid protein in Alzheimer's disease
  73. Reversible inactivation of dihydrolipoamide dehydrogenase by mitochondrial hydrogen peroxide
  74. Telomere Shortening and Alzheimer’s Disease
  75. Neuroprotective Actions of Methylene Blue and Its Derivatives
  76. Roles of AMP-activated Protein Kinase in Alzheimer’s Disease
  77. Ethanol withdrawal acts as an age-specific stressor to activate cerebellar P38 kinase
  78. Chemical probes for analysis of carbonylated proteins: A review
  79. Alternative Mitochondrial Electron Transfer as a Novel Strategy for Neuroprotection
  80. Nongradient blue native gel analysis of serum proteins and in-gel detection of serum esterase activities
  81. Resolving mitochondrial protein complexes using nongradient blue native polyacrylamide gel electrophoresis
  82. Analysis of Oxidative Modification of Proteins
  83. Estrogen Receptor   as a Mitochondrial Vulnerability Factor
  84. Analysis of Oxidative Modification of Proteins
  85. Changes in dihydrolipoamide dehydrogenase expression and activity during postnatal development and aging in the rat brain
  86. Ethanol withdrawal provokes mitochondrial injury in an estrogen preventable manner
  87. Human αB-Crystallin Mutation Causes Oxido-Reductive Stress and Protein Aggregation Cardiomyopathy in Mice
  88. Histochemical staining and quantification of dihydrolipoamide dehydrogenase diaphorase activity using blue native PAGE
  89. Hypoxia-inducible Factor 2  Regulates Expression of the Mitochondrial Aconitase Chaperone Protein Frataxin
  90. Pyruvate protects mitochondria from oxidative stress in human neuroblastoma SK-N-SH cells
  91. Mass spectrometry-based survey of age-associated protein carbonylation in rat brain mitochondria
  92. Mouse HSF1 Disruption Perturbs Redox State and Increases Mitochondrial Oxidative Stress in Kidney
  93. Multiple organ pathology, metabolic abnormalities and impaired homeostasis of reactive oxygen species in Epas1−/− mice
  94. Mouse heat shock transcription factor 1 deficiency alters cardiac redox homeostasis and increases mitochondrial oxidative damage
  95. Analysis of Oxidative Modification of Proteins
  96. Heat shock factor 1 and heat shock proteins: Critical partners in protection against acute cell injury
  97. Prevention of flight activity prolongs the life span of the housefly, Musca domestica, and attenuates the age-associated oxidative damamge to specific mitochondrial proteins
  98. Effects of aging and hyperoxia on oxidative damage to cytochrome c in the housefly, Musca domestica1
  99. Analysis of Oxidative Modification of Proteins
  100. Gel Electrophoretic Quantitation of Protein Carbonyls Derivatized with Tritiated Sodium Borohydride
  101. Mitochondrial adenine nucleotide translocase is modified oxidatively during aging
  102. Identification of Oxidized Proteins Based on Sodium Dodecyl Sulfate–Polyacrylamide Gel Electrophoresis, Immunochemical Detection, Isoelectric Focusing, and Microsequencing
  103. Macromolecular carbonyls in human stratum corneum: a biomarker for environmental oxidant exposure?
  104. UV-Irradiation Depletes Antioxidants and Causes Oxidative Damage in a Model of Human Skin
  105. The Lipoic Acid Analogue 1,2-Diselenolane-3-pentanoic Acid Protects Human Low Density Lipoprotein against Oxidative Modification Mediated by Copper Ion
  106. Oxidative damage during aging targets mitochondrial aconitase
  107. Apolipoprotein B Carbonyl Formation Is Enhanced by Lipid Peroxidation during Copper-Mediated Oxidation of Human Low-Density Lipoproteins
  108. Efficacy of Hypochlorous Acid Scavengers in the Prevention of Protein Carbonyl Formation
  109. Antioxidant Activity of Diethyldithiocarbamate
  110. Spectrophotometric Method for Determination of Carbonyls in Oxidatively Modified Apolipoprotein B of Human Low-Density Lipoproteins
  111. Ginkgo Biloba Extract (EGb 761) Protects Human Low-Density Lipoproteins against Oxidative Modification Mediated by Copper
  112. Oxidative DNA damage and senescence of human diploid fibroblast cells.
  113. Elucidation of Antioxidant Activity of α-Lipoic Acid Toward Hydroxyl Radical
  114. Induction of Protein Oxidation in Human Low Lipoprotein by the Photosensitive Organic Hydroperoxide, N,N′-bis(2-Hydroxyperoxy-2-Methoxyethyl)-1,4,5,8-Naphthalene-Tetra-Carboxylic-Diimide
  115. Effects of oxygen radicals on the conformation of sulfhydryl groups on human polymorphonuclear leukocyte membranes
  116. Experimental studies on some aspects of toxicological effects of gas phase cigarette smoke (GPCS)